Cresemba (isavuconazonium sulfate or isavuconazole) — Blue Cross Blue Shield of Montana

Initial criteria

• ONE of the following:
• • Patient has a diagnosis of invasive aspergillosis
• • Patient has a diagnosis of invasive mucormycosis
• • Patient has another FDA labeled indication for the requested agent and route of administration
• • Patient has another indication that is supported in compendia for the requested agent and route of administration
• AND Patient does NOT have any FDA labeled contraindications to the requested agent

Approval duration

6 months